Literature DB >> 2862320

Continuous intrathecal baclofen for severe spasticity.

R D Penn, J S Kroin.   

Abstract

Baclofen is the most effective drug for the treatment of rigidity and spasms caused by damage to the spinal cord, but frequently, relatively little relief is afforded and dose is limited by central side-effects. To improve the efficiency of drug delivery 6 patients received implantable programmable pumps with a catheter going into the lumbar subarachnoid space. Baclofen, at doses of 12 micrograms to 400 micrograms per day, was given for up to 7 months. With intraspinal treatment there was an immediate reduction of muscle tone to normal levels, and spontaneous spasms were eliminated. Patients experienced less discomfort, and daily activities were more easily accomplished.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862320     DOI: 10.1016/s0140-6736(85)90228-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  Intrathecal drug administration. Present use and future trends.

Authors:  J S Kroin
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Trends in the pathophysiology and pharmacotherapy of spasticity.

Authors:  J Noth
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

Review 3.  Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS.

Authors:  Mikhail I Papisov; Vasily V Belov; Kimberley S Gannon
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

4.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.

Authors:  G Ochs; A Struppler; B A Meyerson; B Linderoth; J Gybels; B P Gardner; P Teddy; A Jamous; P Weinmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

5.  The effect of intrathecal baclofen on electrical muscle activity in spasticity.

Authors:  H Müller; J Zierski; D Dralle; U Börner; O Hoffmann
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

6.  Treatment of severe tetanus by continuous intrathecal infusion of baclofen.

Authors:  H Brock; W Moosbauer; C Gabriel; S Necek; D Bidal
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

7.  Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.

Authors:  A Zahavi; J H B Geertzen; B Middel; M Staal; J S Rietman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

8.  Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump.

Authors:  V Patterson; M Watt; D Byrnes; D Crowe; A Lee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

9.  Intraspinal baclofen in the treatment of severe spasticity and spasms.

Authors:  J Sahuquillo; T Muxi; M Noguer; R Jodar; C Closa; E Rubio; L Garcia-Fernandez; J M Guitart
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

10.  [Intrathecal and epidural administration of non-opioid analgesics in acute and chronic pain treatment.].

Authors:  B Donner; M Tryba; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.